Niagen Bioscience Inc (NAGE)
NASDAQ: NAGE
· Real-Time Price · USD
13.80
-0.08 (-0.58%)
At close: Jun 18, 2025, 3:59 PM
13.71
-0.65%
After-hours: Jun 18, 2025, 07:35 PM EDT
-0.58% (1D)
| Bid | 13.7 |
| Market Cap | 1.09B |
| Revenue (ttm) | 107.92M |
| Net Income (ttm) | 14.11M |
| EPS (ttm) | 0.18 |
| PE Ratio (ttm) | 76.67 |
| Forward PE | 58.79 |
| Analyst | Strong Buy |
| Ask | 14.1 |
| Volume | 762,165 |
| Avg. Volume (20D) | 910,745.2 |
| Open | 13.88 |
| Previous Close | 13.88 |
| Day's Range | 13.31 - 14.14 |
| 52-Week Range | 2.31 - 14.49 |
| Beta | 2.08 |
About NAGE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NAGE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NAGE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
+12.51%
Niagen Bioscience shares are trading higher after ...
Unlock content with
Pro Subscription
1 month ago
+9.35%
Niagen Bioscience shares are trading higher after the company reported better-than-expected Q1 financial results and raised its fY25 revenue guidance.
1 month ago · businesswire.com
Niagen Bioscience Welcomes Dr. Pinchas Cohen to Scientific Advisory BoardLOS ANGELES--(BUSINESS WIRE)---- $NAGE #Bioscience--Niagen Bioscience, Inc. (NASDAQ: NAGE) (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on ...
